IDET — Intradiscal Electrothermal Therapy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Intradiscal Electrothermal Therapy (IDET) is a minimally invasive outpatient or day-surgery procedure designed to treat chronic discogenic low back pain arising from internal disc disruption and annular fissures. First introduced in the late 1990s by Saal and Saal, IDET involves the fluoroscopically guided insertion of a flexible, electrothermal catheter (SpineCATH — originally Smith and Nephew ArthroCare) into the nucleus pulposus of the symptomatic intervertebral disc. The catheter tip is then progressively heated from 65 degrees Celsius to a target temperature of 90 degrees Celsius over 13–17 minutes and maintained at this temperature for the final portion of the heating cycle.

The proposed therapeutic mechanisms of IDET — though not yet fully elucidated — include: (1) collagen remodelling: thermal denaturation and subsequent remodelling of collagen fibrils in the posterior annulus fibrosus, aiming to restore structural integrity and reduce fissure propagation; (2) nociceptor ablation: thermal destruction of the free nerve endings and nociceptive fibres that have pathologically in-grown into the inner annulus and nucleus pulposus in discogenic pain states; and (3) reduction of inflammatory mediators in the disc environment that sensitise peripheral nociceptors.

IDET targets a specific and carefully defined pain generator: the posterolateral annular fissure demonstrated on MRI and confirmed by positive concordant pain reproduction on provocative discography. It is not a treatment for radicular (nerve root) pain, spinal stenosis, or facet-mediated pain, and patient selection is critical to achieving acceptable outcomes. IDET is performed under local anaesthesia with conscious sedation (IV fentanyl and midazolam) on a day-surgery basis and typically requires 60–90 minutes including the fluoroscopy setup, catheter placement, heating cycle, and recovery. Patients are discharged with a lumbar brace and a structured activity-restriction programme for the first 6–8 weeks.

IDET is indicated for a narrow and well-characterised subset of patients with chronic low back pain specifically attributable to internal disc disruption (IDD) and posterior annular pathology. The appropriate diagnostic category is chronic discogenic low back pain — defined as axial low back pain (predominantly below L3, without significant leg pain or radiculopathy) persisting for 6 or more months, arising from one or more lumbar intervertebral discs with demonstrable annular pathology.

The target pathology identified on imaging and provocation testing includes:

• Posterior annular fissures or tears visible on MRI as high-intensity zones (HIZ) — hyperintense signal within the posterior annulus on T2-weighted sequences — indicating disruption of the outer annular fibres and associated inflammatory neovascularisation.
• Internal disc disruption (IDD) with degradation of the nucleus pulposus and fissure propagation demonstrated on MRI and confirmed by positive concordant pain on discography.
• Grade 3 or higher annular disruption on Dallas Discogram Scale during provocative discography.

IDET is not appropriate for:

• Lumbar radiculopathy or disc herniation causing nerve root compression
• Spinal stenosis (central or lateral recess) causing neurogenic claudication
• Facet-mediated pain (responds to medial branch blocks and radiofrequency ablation)
• Sacroiliac joint dysfunction
• Spondylolisthesis with significant instability
• Non-specific low back pain without an identifiable discogenic pain generator

Careful diagnostic workup — including MRI, provocative discography with adjacent negative control level, and a trial of conservative management — is mandatory before IDET is considered. The diagnostic specificity of discography remains contested, and positive discography findings must be interpreted in the context of the patient's clinical presentation and psychological profile.

IDET requires the most rigorous patient selection criteria of any spinal interventional procedure, as outcomes are closely correlated with adherence to published inclusion criteria. The following criteria must typically be satisfied before IDET is offered:

Mandatory Inclusion Criteria:

• Duration and nature of pain: Chronic axial low back pain (axial predominant, not radicular) persisting for 6 or more months, causing functional impairment and not responding to a comprehensive conservative management programme.
• Failed conservative care: The patient must have completed a minimum 6-month course of conservative treatment including supervised physiotherapy with a structured exercise programme, oral analgesics and NSAIDs at appropriate doses, and consideration of epidural steroid injections or trigger point injections where indicated.
• Positive provocative discography: Concordant pain reproduction (pain identical or very similar to the patient's typical pain) at the target disc level at a pressure below 50 psi above opening pressure, with a morphologically abnormal appearance on post-discography CT, and negative control at an adjacent non-painful level.
• MRI findings: Evidence of disc degeneration and posterior annular disruption at the symptomatic level(s). High-intensity zone on T2-weighted MRI is a supportive finding.
• Preserved disc height: The target disc must retain at least 50% of normal disc height. IDET requires sufficient disc space to accommodate the catheter, and severely collapsed discs are technically not amenable to the procedure.
• Contained disc: No significant disc herniation with fragment migration (sequestration), as extruded or sequestered fragments are not targeted by IDET.

Relative Contraindications: Spinal stenosis at the target level; spondylolisthesis above Grade 1; severe spinal deformity; active infection; coagulopathy; BMI above 35 (technical difficulty); pregnancy; significant psychological comorbidity (untreated depression, somatisation disorder, or active compensation litigation may predict poor outcomes and should prompt psychological evaluation prior to IDET); prior spinal surgery at the target level.

Age Consideration: IDET is most commonly performed in patients aged 20–55 years with disc pathology but preserved disc height. Elderly patients with advanced multi-level degeneration and significantly reduced disc height are generally not candidates.

IDET is performed by an interventional spine specialist — typically a pain medicine physician, orthopaedic spine surgeon, or neurosurgeon with specific training in intradiscal procedures — in a fluoroscopy suite or operating theatre under strict sterile conditions.

Pre-Procedure Preparation: Patients fast for 4–6 hours before the procedure. Intravenous access is established and prophylactic antibiotics (typically cefazolin 1 g IV, or clindamycin if penicillin-allergic) are administered 30 minutes before the procedure. Conscious sedation is achieved with intravenous fentanyl and midazolam, titrated to produce moderate sedation while preserving the patient's ability to communicate any paraesthetic or sharp pain during catheter positioning.

Fluoroscopic Guidance and Needle Placement: Under anteroposterior and lateral fluoroscopic guidance, a 17-gauge introducer needle is inserted into the posterolateral approach to the nucleus pulposus of the target disc using an oblique extrapedicular technique. The needle tip is positioned at the posterior junction of the nucleus pulposus and the inner annulus fibrosus.

Catheter Insertion and Positioning: A flexible electrothermal catheter (SpineCATH or equivalent) is advanced through the introducer needle. Its thermally active distal tip is navigated around the inner posterior annulus under real-time fluoroscopy, positioning the active heating element along the posterior and posterolateral annular wall — the target region harbouring annular fissures and in-grown nociceptive fibres.

Heating Protocol: The catheter generator delivers controlled radiofrequency current to heat the catheter tip in a stepwise fashion: beginning at 65 degrees Celsius and increasing by 1 degree Celsius per minute to a target of 90 degrees Celsius. The target temperature is maintained for the final 4 minutes of the cycle. The entire heating cycle takes approximately 13–17 minutes. Throughout heating, the patient is monitored for concordant or non-concordant pain reproduction, which guides catheter repositioning if needed.

Post-Procedure Care: After catheter removal, the patient is observed for 1–2 hours. A rigid or semi-rigid lumbar brace is prescribed and must be worn consistently for 6–8 weeks. Patients are advised to avoid sitting for more than 20 minutes at a time, lifting more than 5–10 kg, bending and twisting, and vigorous physical activity during the recovery period. Structured physiotherapy commences at 6–8 weeks, progressing from core stabilisation exercises to aerobic conditioning.

In carefully selected patients meeting all published inclusion criteria, IDET offers several potential advantages over continued conservative management or immediate surgery:

• Minimally Invasive Approach: IDET is performed under local anaesthesia and conscious sedation as an outpatient or day-surgery procedure. There are no surgical incisions, no spinal fusion hardware, no bone graft, and no general anaesthesia in most cases. Recovery time is substantially shorter than open spinal surgery.
• Avoidance of Spinal Fusion: For patients with single-level discogenic pain who meet IDET criteria, a successful IDET procedure may defer or avoid lumbar fusion — the principal alternative surgical treatment — with its risks of adjacent segment disease (accelerated degeneration at levels adjacent to a fused segment), pseudarthrosis, hardware failure, and longer recovery.
• Published Clinical Outcomes: Several prospective cohort studies (Saal and Saal, 2000, 2002) reported that 60–80% of selected patients achieved clinically meaningful reductions in pain scores (VAS) and functional improvement (SF-36 physical function subscale) at 12–24 months. However, these early results were from unblinded non-randomised studies with potential selection bias.
• Randomised Controlled Trial Evidence: Two blinded RCTs have produced conflicting results. Pauza et al. (Spine, 2004) demonstrated statistically significant and clinically meaningful improvements in pain and disability compared with sham procedure at 6 months in a cohort with confirmed discogenic pain. Freeman et al. (Spine, 2005) found no statistically significant difference between IDET and sham in a similarly selected UK cohort. This discrepancy has generated ongoing debate about patient selection, catheter positioning, and outcome measurement methodology.
• Relatively Low Complication Rate: When performed by an experienced operator in appropriately selected patients, the major complication rate of IDET is estimated at 0.5–1.5%, substantially lower than the complication rate associated with lumbar fusion surgery.

IDET carries a set of specific procedural risks that patients must understand and weigh against the potential benefits and the natural history of untreated discogenic pain:

• Procedure Failure / No Benefit: The most common adverse outcome. Despite careful selection, 25–40% of patients report no significant improvement in pain or function at 6 months. In these patients, alternative management pathways must be reconsidered. Prior IDET does not preclude subsequent spinal fusion.
• Discitis (Disc Space Infection): The most serious complication, occurring in approximately 0.1–0.5% of procedures. Discitis typically presents 2–8 weeks post-procedure with worsening back pain, fever, elevated CRP, and elevated ESR. MRI shows disc space and endplate signal changes. Treatment requires prolonged IV antibiotics (6 weeks or more) and, in severe cases, surgical debridement. Strict sterile technique and prophylactic antibiotics reduce but do not eliminate this risk.
• Nerve Root Injury: Thermal injury to an adjacent nerve root can occur if catheter placement deviates from the intranuclear position. Presents as new or worsening leg pain or neurological deficit. Rare when performed under careful fluoroscopic guidance, but potentially serious.
• Catheter Breakage: Early-generation SpineCATH catheters had a reported fracture rate of approximately 0.3%. Catheter fragments retained within the disc are generally inert but may complicate subsequent surgical procedures. Advances in catheter design have reduced this risk.
• Post-Procedure Pain Flare: A transient worsening of low back pain lasting days to weeks following the procedure is common (up to 30% of patients) and usually self-limiting. Analgesics and activity modification are used during this period.
• Disc Herniation: Theoretical risk of converting a contained annular fissure into a disc herniation with nerve root compression, though this appears to be rare in published series.
• Worsening of Disc Degeneration: Some laboratory data suggest that thermal exposure may accelerate degeneration in adjacent disc tissues. The clinical significance of this finding in human patients is uncertain.

Recovery after IDET is a structured, phased process. Patients should understand that pain relief following IDET is not immediate — the therapeutic collagen remodelling and nociceptor ablation effects develop over weeks to months — and that the post-procedure activity restriction period is critical to the outcome.

Weeks 1–6 (Activity Restriction Phase): Patients wear a rigid or semi-rigid lumbar brace consistently during waking hours. Activity is restricted to gentle walking (initially 10–15 minutes, increasing gradually). Sitting is limited to 20 minutes continuously. No bending, lifting, or twisting. Over-the-counter analgesics (paracetamol, NSAIDs) are used for pain management. Patients are typically off work during this phase unless they have a sedentary occupation with access to sit-stand arrangements.

Weeks 6–12 (Physiotherapy Phase): Supervised physiotherapy commences, beginning with core stabilisation exercises (transversus abdominis and multifidus activation, McGill Big Three), progressing to low-impact aerobic conditioning (walking, swimming, cycling), and advancing to functional strengthening by 12 weeks. Brace use is progressively weaned during this phase.

Months 3–6 (Rehabilitation and Assessment Phase): Patients return to normal daily activities with progressive loading. A formal clinical reassessment at 3 and 6 months evaluates pain scores (NRS, VAS), disability (Oswestry Disability Index, ODI), and patient satisfaction. Patients who have not achieved meaningful improvement at 6 months should undergo repeat MRI to assess disc status and should be referred for reassessment of the diagnosis and discussion of alternative treatments including basivertebral nerve ablation or surgical consultation.

Long-Term Follow-Up: Observational data from Saal and Saal suggest that improvements achieved at 12 months following IDET tend to be sustained at 2 years in responders. However, ongoing adherence to a structured exercise and lifestyle programme — including weight management, smoking cessation, and avoiding repetitive spinal loading — is essential to long-term outcomes.

IDET is a moderately expensive outpatient interventional procedure, and costs vary significantly by country, facility type, and payer status. The following factors influence the total cost:

• Procedure Fee and Facility: In the United States, the total cost of an IDET procedure — including physician fee, fluoroscopy facility fee, disposable catheter (SpineCATH), and conscious sedation — typically ranges from approximately USD 3,500 to USD 8,000 per level. In the United Kingdom and Europe, comparable procedures range from GBP 2,000 to GBP 5,000 as a private-pay procedure; NHS funding is not routinely available for IDET given NICE guidance reflecting uncertainty in the evidence base.
• Diagnostic Workup Costs: The mandatory pre-procedure workup includes lumbar MRI (USD 800–2,500 if out-of-pocket), lumbar discography with post-discography CT (USD 2,000–5,000 — this is an invasive procedure itself and may be a separate facility cost), and physiotherapy programme documentation.
• Number of Levels Treated: IDET is typically performed at one or two adjacent symptomatic disc levels per session. Treating multiple levels increases procedural cost, catheter cost, and fluoroscopy time. Treating more than two levels at one session is not generally recommended.
• Anaesthesia Type: Conscious IV sedation by the proceduralist is less expensive than full monitored anaesthesia care (MAC) by an anaesthesiologist. Some institutions require anaesthesiology support, adding USD 500–1,500 to the cost.
• Post-Procedure Rehabilitation: 8–12 weeks of supervised physiotherapy represents an additional cost of USD 1,500–4,000 depending on session frequency and insurance coverage.
• Insurance Coverage: In the US, insurance coverage for IDET is inconsistent. Major payers (including some Blue Cross Blue Shield plans and Medicare) classify IDET as investigational and do not routinely reimburse. Patients should obtain prior authorisation and understand their out-of-pocket liability before scheduling the procedure.

Given the modest and contested evidence base for IDET, clinicians and patients should carefully review alternative treatments for chronic discogenic low back pain before committing to an intradiscal procedure:

• Optimised Conservative Management: Many patients with discogenic pain have not completed a truly comprehensive conservative programme. Evidence-based conservative care includes: supervised physiotherapy with motor control and McKenzie method techniques; cognitive-behavioural therapy (CBT) for chronic pain, which improves function independently of pain intensity; multidisciplinary pain rehabilitation programmes (pain schools); and optimised pharmacological management (tricyclics such as amitriptyline, duloxetine, gabapentinoids with caution given limited evidence in axial LBP).
• Basivertebral Nerve Ablation (Intracept Procedure): A direct competitor to IDET for vertebrogenic low back pain arising from the vertebral endplate rather than the annulus. A bipolar radiofrequency probe is inserted into the vertebral body under fluoroscopy and advanced to the basivertebral foramen, ablating the basivertebral nerve that innervates the vertebral endplate. The INTRACEPT randomised trial (2021, NEJM Evidence) demonstrated statistically and clinically significant improvements in ODI and VAS at 3, 6, and 12 months versus sham, with durable benefit at 5-year follow-up — currently providing the strongest RCT evidence among intradiscal procedures. Appropriate for Modic type 1 or 2 endplate changes on MRI.
• Intradiscal Biologics (IDVP / PRP): Intradiscal injection of platelet-rich plasma (PRP), mesenchymal stem cells, or growth factors (BMP, GDF-5) is under active investigation as a regenerative approach to disc degeneration. Current RCT evidence is insufficient to support routine clinical use, but trials are ongoing.
• Percutaneous Disc Nucleoplasty (Coblation): Uses plasma-mediated radiofrequency to ablate a small volume of nuclear tissue, reducing intradiscal pressure. Potentially useful for contained disc herniation causing radicular pain — a different indication from IDET.
• Lumbar Spinal Fusion (TLIF / PLIF / ALIF): The definitive surgical treatment for refractory single-level discogenic pain not responsive to conservative management or minimally invasive procedures. Involves removing the disc, inserting an interbody cage and bone graft, and achieving posterior pedicle screw fixation. Effective in carefully selected patients (60–70% satisfaction at 2 years in RCTs vs conservative care in the SPORT trial subgroup), but carries risks of adjacent segment disease, pseudarthrosis, infection, and longer recovery.
• Total Disc Replacement (TDR — Arthroplasty): Artificial disc prosthesis (ProDisc-L, Charité) to preserve motion while removing the pain-generating disc. Approved for single-level L4–S1 discogenic pain in appropriately selected patients. RCT data show non-inferiority to lumbar fusion at 24 months, with theoretical advantages of motion preservation and lower rates of adjacent segment disease.